A KU team led by School of Pharmacy Distinguished Professor David Volkin is working hard to develop the next generation of life-saving vaccines aimed at protecting 100% of the world’s children. On the strength of three new research grants and a service contract totaling approximately $10 million from the Bill & Melinda Gates Foundation, Volkin and co-investigator Sangeeta Joshi recently launched the Vaccine Analytics & Formulation Center (VAFC) to advance vaccine candidates for the developing world.